These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30468862)

  • 1. Translational research on chemical nerve agents.
    Jett DA; Spriggs SM
    Neurobiol Dis; 2020 Jan; 133():104335. PubMed ID: 30468862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NIH Countermeasures Against Chemical Threats Program: overview and special challenges.
    Jett DA
    Ann N Y Acad Sci; 2016 Jun; 1374(1):5-9. PubMed ID: 27398820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CounterACT Research Network: basic mechanisms and practical applications.
    Jett DA; Yeung DT
    Proc Am Thorac Soc; 2010 Jul; 7(4):254-6. PubMed ID: 20601628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Linolenic Acid, A Nutraceutical with Pleiotropic Properties That Targets Endogenous Neuroprotective Pathways to Protect against Organophosphate Nerve Agent-Induced Neuropathology.
    Piermartiri T; Pan H; Figueiredo TH; Marini AM
    Molecules; 2015 Nov; 20(11):20355-80. PubMed ID: 26569216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides.
    Gorecki L; Korabecny J; Musilek K; Malinak D; Nepovimova E; Dolezal R; Jun D; Soukup O; Kuca K
    Arch Toxicol; 2016 Dec; 90(12):2831-2859. PubMed ID: 27582056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.
    Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
    Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding new cures for neurological disorders: a possible fringe benefit of biodefense research?
    Jett DA
    Sci Transl Med; 2010 Mar; 2(23):23ps12. PubMed ID: 20375001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and Challenges in Developing Medical Countermeasures for Chemical, Biological, Radiological, and Nuclear Threat Agents.
    Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):260-267. PubMed ID: 38233227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blaptica dubia as sentinels for exposure to chemical warfare agents - a pilot study.
    Worek F; Seeger T; Neumaier K; Wille T; Thiermann H
    Toxicol Lett; 2016 Nov; 262():12-16. PubMed ID: 27639501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosgene oxime: a highly toxic urticant and emerging chemical threat.
    Singh SK; Klein JA; Wright HN; Tewari-Singh N
    Toxicol Mech Methods; 2021 May; 31(4):288-292. PubMed ID: 33297803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxic disorders of organophosphorus compounds and their managements.
    Balali-Mood M; Balali-Mood K
    Arch Iran Med; 2008 Jan; 11(1):65-89. PubMed ID: 18154426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology.
    McDonough JH; Shih TM
    Neurosci Biobehav Rev; 1997 Sep; 21(5):559-79. PubMed ID: 9353792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicology of organophosphorus compounds in view of an increasing terrorist threat.
    Worek F; Wille T; Koller M; Thiermann H
    Arch Toxicol; 2016 Sep; 90(9):2131-2145. PubMed ID: 27349770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hydrogen sulfide-induced neuropathology and neurological sequelae: challenges for translational neuroprotective research.
    Rumbeiha W; Whitley E; Anantharam P; Kim DS; Kanthasamy A
    Ann N Y Acad Sci; 2016 Aug; 1378(1):5-16. PubMed ID: 27442775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIH Roundtable on Opportunities to Advance Research on Neurologic and Psychiatric Emergencies.
    D'Onofrio G; Jauch E; Jagoda A; Allen MH; Anglin D; Barsan WG; Berger RP; Bobrow BJ; Boudreaux ED; Bushnell C; Chan YF; Currier G; Eggly S; Ichord R; Larkin GL; Laskowitz D; Neumar RW; Newman-Toker DE; Quinn J; Shear K; Todd KH; Zatzick D;
    Ann Emerg Med; 2010 Nov; 56(5):551-64. PubMed ID: 21036295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The delayed neuropathic effects of nerve agents and some other organophosphorus compounds.
    Gordon JJ; Inns RH; Johnson MK; Leadbeater L; Maidment MP; Upshall DG; Cooper GH; Rickard RL
    Arch Toxicol; 1983 Feb; 52(2):71-82. PubMed ID: 6847383
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemical warfare. Nerve agent poisoning.
    Holstege CP; Kirk M; Sidell FR
    Crit Care Clin; 1997 Oct; 13(4):923-42. PubMed ID: 9330846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects.
    Collombet JM
    Toxicol Appl Pharmacol; 2011 Sep; 255(3):229-41. PubMed ID: 21791221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements of acetylcholinesterase reactivators.
    Kuca K; Juna D; Musilek K
    Mini Rev Med Chem; 2006 Mar; 6(3):269-77. PubMed ID: 16515465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perspectives in the treatments of poisonings by organophosphorus insecticides and warfare nerve agents].
    Sogorb-Sánchez MA; Vilanova-Gisbert E; Carrera-González V
    Rev Neurol; 2004 Oct 16-31; 39(8):739-47. PubMed ID: 15514903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.